Agresta, L., Lehn, M., Lampe, K., Cantrell, R., Hennies, C., Szabo, S., Wise-Draper, T., Conforti, L., Hoebe, K. and Janssen, E. M. CD244 represents a new therapeutic target in head and neck squamous cell carcinoma. Journal For Immunotherapy Of Cancer. 2020; 8(1), e000245. doi: 10.1136/jitc-2019-000245
Menu
